Innovent Biologics, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Innovent Biologics, Inc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 38.46% vs 48.96% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 959.94% vs 90.97% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,143.80",
          "val2": "10,215.40",
          "chgp": "38.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,844.40",
          "val2": "613.10",
          "chgp": "363.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "86.30",
          "val2": "73.30",
          "chgp": "17.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.60",
          "val2": "154.70",
          "chgp": "-99.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "882.30",
          "val2": "-102.60",
          "chgp": "959.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "155.00%",
          "val2": "15.50%",
          "chgp": "13.95%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

14,143.80

10,215.40

38.46%

Operating Profit (PBDIT) excl Other Income

2,844.40

613.10

363.94%

Interest

86.30

73.30

17.74%

Exceptional Items

0.60

154.70

-99.61%

Consolidate Net Profit

882.30

-102.60

959.94%

Operating Profit Margin (Excl OI)

155.00%

15.50%

13.95%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 38.46% vs 48.96% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 959.94% vs 90.97% in Dec 2024

All Annual Results